SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model

Commun Biol. 2022 Oct 27;5(1):1138. doi: 10.1038/s42003-022-04068-3.

Abstract

SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air-liquid interface to estimate replication and epidemic potential of respiratory viruses in the human lower respiratory tract. hAELVI cultures are highly permissive for different human coronaviruses and seasonal influenza A virus and upregulate various mediators following virus infection. Our analysis revealed a significantly reduced capacity of SARS-CoV-2 Omicron BA.1 and BA.2 variants to propagate in this human model compared to earlier D614G and Delta variants, which extends early risk assessments from epidemiological and animal studies suggesting a reduced pathogenicity of Omicron.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COVID-19*
  • Epithelial Cells
  • Humans
  • Lung
  • SARS-CoV-2* / genetics

Supplementary concepts

  • SARS-CoV-2 variants